$38.15+0.73 (+1.95%)
Value Line, Inc.
Value Line, Inc. in the Financial Services sector is trading at $38.15 with a market capitalization of $326M. The stock is currently 7% below its 52-week high of $41.18, remaining 5.2% above its 200-day moving average. On fundamentals, Piotroski 6/9 shows mixed financial quality, Altman Z in the safe zone. The Whystock Score of 95/100 reflects bullish alignment across trend, valuation and analyst targets.
| Metric (USD) | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|
| Total Revenue | $8.28Mβ | $8.56Mβ | $8.61Mβ | $8.39Mβ | $8.97M |
| Gross Profit | $4.66Mβ | $5.06Mβ | $4.99Mβ | $4.67Mβ | $5.34M |
| Operating Income | $1.00Mβ | $1.51Mβ | $1.50Mβ | $830,000β | $1.56M |
| Net Income | $5.91Mβ | $5.68Mβ | $6.46Mβ | $3.95Mβ | $5.16M |
Value Line, Inc. engages in the production and sale of investment periodicals and related publications. Its investment periodicals and related publications cover a range of investments, including stocks, mutual funds, exchange traded funds (ETFs), an...
Strong cash, recurring EAM income, expanding digital research, rising dividends and a trusted brand position VALU for long-term growth.
SpaceX faces valuation and execution concerns, but its leadership in satellite connectivity and reusable launches supports long-term growth prospects.
Today's Research Daily features new research reports on 16 major stocks, including Space Exploration Technologies Corp. (SPCX), Meta Platforms, Inc. (META) and The Boeing Company (BA), as well as a micro-cap stock, Value Line, Inc. (VALU).
SELLAS Life Sciences (SLS) has surged 550% in the past year, driven by technical momentum and speculative trading. SLS currently has no revenue, with all products in development or clinical trials, making the stock highly speculative. Technical indicators are overwhelmingly bullish, but high short interest highlights significant risk. Sentiment is...
<p>Options strategies continue to flood the ETF market, offering investors a wide variety of ways to earn income on stock movements. One ETF, however, banks on stocks staying rangebound for its income when others bet big on outsized swings. Tune into this <em>Behind the Ticker</em> episode to learn how one option ETF takes a different spin on earnings season, and how you can benefit.Β </p>